Skip to content
Clinical Trials – home
LuxembourgBack to Luxembourg

Clinical trials in Luxembourg

8 clinical trials in Luxembourg, Luxembourg across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Luxembourg at a glance
8
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

8 trials in Luxembourg

Open in trial search
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Fondazione Ricerca e Innovazione Cardiovascolare
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Adipose-Derived Stem Cells
  • Sponsor:Novadip Biosciences
Countries:LuxembourgLuxembourg
  • Participants:18–64 years
  • Substances:Nvdx3
  • Sponsor:Novadip Biosciences
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Prasinezumab
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Prasinezumab
  • Sponsor:F. Hoffmann-La Roche AG

Lung disorder

Not recruiting
Registered drugNo placebo
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Oslo University Hospital HF
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Bemcentinib
  • Sponsor:Oslo University Hospital HF

Other cities in Luxembourg

The busiest research cities in the country

All 2 cities in Luxembourg

Clinical research in Luxembourg

What the registry says about research in the country

01 Orthopedic Research

Innovative studies focusing on bone reconstruction and healing, particularly examining advanced treatment options for challenging limb conditions and fractures.

  • Lower limb nonunion treatment
  • Lumbar spondylolisthesis therapy
  • Distal radius fracture management

Research emphasizes novel osteogenic implants and their long-term safety profiles in various skeletal conditions.

02 Neurology Studies

Ground-breaking research in Parkinson's disease treatment, investigating new therapeutic approaches for early-stage patients.

  • Motor progression assessment
  • Novel drug interventions
  • Early-stage disease management

Trials focus on evaluating innovative treatments to slow disease progression and improve patient outcomes.

03 Oncology Research

Advanced studies in Small Cell Lung Cancer treatment, exploring combination therapies for extensive disease states.

  • First-line therapy evaluation
  • Immunotherapy combinations
  • Systemic treatment approaches

Research aims to enhance treatment efficacy through innovative drug combinations.

04 Infectious Disease Studies

Comprehensive research on COVID-19 treatments, investigating multiple therapeutic approaches for varying disease severities.

  • Moderate COVID-19 management
  • Severe disease intervention
  • Immunocompromised patient care

Trials evaluate novel therapeutic agents and their efficacy in different patient populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).